Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Apr;90(4):641–650. doi: 10.1111/j.1476-5381.1987.tb11216.x

Glutamate-evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue.

K Jhamandas, M Marien
PMCID: PMC1917217  PMID: 2884003

Abstract

The present study examined the effect of a selective delta-opioid receptor agonist [D-Ala2-D-Leu5] enkephalin (DADL) on the spontaneous and the L-glutamic acid (L-Glu)-evoked release of endogenous dopamine from superfused slices of rat caudate-putamen. The amount of dopamine in slice superfusates was measured by a sensitive method employing high-performance liquid chromatography with electrochemical detection (h.p.l.c.-e.d.) after a two-step separation procedure. The spontaneous release of endogenous dopamine was partially dependent on Ca2+, enhanced in Mg2+-free superfusion medium, partially reduced by tetrodotoxin (TTX, 0.3 microM), partially reduced by the putative excitatory amino acid receptor antagonist DL-2-amino-7-phosphonoheptanoic acid (DL-APH, 1 mM), and increased 10 fold by the dopamine uptake blocker, nomifensine (10 microM). DADL (5 and 50 nM) did not significantly affect spontaneous dopamine release. L-Glu (0.1-10 mM) produced a concentration-dependent release of endogenous dopamine from slices of caudate-putamen. This effect was Ca2+-dependent, strongly inhibited by 1.2 mM Mg2+, attenuated by DL-APH (1 mM), attenuated by TTX (0.3 microM), and enhanced by nomifensine (10 microM). In the presence of nomifensine DADL (50 nM) reduced significantly the L-Glu-evoked release of endogenous dopamine by 20%. The inhibitory effect of DADL was blocked by 10 microM naloxone. These results indicate that L-Glu stimulates the Ca2+-dependent release of endogenous dopamine in the caudate-putamen by activation of N-methy-D-aspartate-type of excitatory amino acid receptors. This release can be selectively modified by the delta-opioid agonist DADL in a naloxone-sensitive manner.

Full text

PDF
641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbilla S., Langer S. Z. Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature. 1978 Feb 9;271(5645):559–561. doi: 10.1038/271559a0. [DOI] [PubMed] [Google Scholar]
  2. Barker J. L., Neale J. H., Smith T. G., Jr, Macdonald R. L. Opiate peptide modulation of amino acid responses suggests novel form of neuronal communication. Science. 1978 Mar 31;199(4336):1451–1453. doi: 10.1126/science.204016. [DOI] [PubMed] [Google Scholar]
  3. Broderick P. A., Blaha C. D., Lane R. F. In vivo electrochemical evidence for an enkephalinergic modulation underlying stereotyped behavior: reversibility by naloxone. Brain Res. 1983 Jun 20;269(2):378–381. doi: 10.1016/0006-8993(83)90151-8. [DOI] [PubMed] [Google Scholar]
  4. Evans R. H., Francis A. A., Jones A. W., Smith D. A., Watkins J. C. The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br J Pharmacol. 1982 Jan;75(1):65–75. doi: 10.1111/j.1476-5381.1982.tb08758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. George S. R., Van Loon G. R. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum. Brain Res. 1982 Sep 30;248(2):293–303. doi: 10.1016/0006-8993(82)90587-x. [DOI] [PubMed] [Google Scholar]
  6. Goodman R. R., Snyder S. H., Kuhar M. J., Young W. S., 3rd Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6239–6243. doi: 10.1073/pnas.77.10.6239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamilton M. G., Hirst M., Blum K. Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileum. Life Sci. 1979 Dec 24;25(26):2205–2210. doi: 10.1016/0024-3205(79)90093-6. [DOI] [PubMed] [Google Scholar]
  8. Hamlet M. A., Rorie D. K., Tyce G. M. Release of endogenous catecholamines from slices of hypothalamus of rats. Brain Res. 1981 Aug 3;217(2):315–325. doi: 10.1016/0006-8993(81)90007-x. [DOI] [PubMed] [Google Scholar]
  9. Jhamandas K., Dumbrille A. Regional release of [3H]adenosine derivatives from rat brain in vivo: effect of excitatory amino acids, opiate agonists, and benzodiazepines. Can J Physiol Pharmacol. 1980 Nov;58(11):1262–1278. doi: 10.1139/y80-193. [DOI] [PubMed] [Google Scholar]
  10. Loh H. H., Brase D. A., Sampath-Khanna S., Mar J. B., Way E. L., Li C. H. beta-Endorphin in vitro inhibition of striatal dopamine release. Nature. 1976 Dec 9;264(5586):567–568. doi: 10.1038/264567a0. [DOI] [PubMed] [Google Scholar]
  11. Lubetzki C., Chesselet M. F., Glowinski J. Modulation of dopamine release in rat striatal slices by delta opiate agonists. J Pharmacol Exp Ther. 1982 Aug;222(2):435–440. [PubMed] [Google Scholar]
  12. Marien M., Brien J., Jhamandas K. Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid. Can J Physiol Pharmacol. 1983 Jan;61(1):43–60. doi: 10.1139/y83-005. [DOI] [PubMed] [Google Scholar]
  13. Mulder A. H., Wardeh G., Hogenboom F., Frankhuyzen A. L. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 1984 Mar 15;308(5956):278–280. doi: 10.1038/308278a0. [DOI] [PubMed] [Google Scholar]
  14. Perkins M. N., Collins J. F., Stone T. W. Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants. Neurosci Lett. 1982 Sep 20;32(1):65–68. doi: 10.1016/0304-3940(82)90230-0. [DOI] [PubMed] [Google Scholar]
  15. Pollard H., Llorens C., Schwartz J. C., Gros C., Dray F. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Res. 1978 Aug 4;151(2):392–398. doi: 10.1016/0006-8993(78)90895-8. [DOI] [PubMed] [Google Scholar]
  16. Raiteri M., Cerrito F., Cervoni A. M., del Carmine R., Ribera M. T., Levi G. Studies on dopamine uptake and release in synaptosomes. Adv Biochem Psychopharmacol. 1978;19:35–56. [PubMed] [Google Scholar]
  17. Roberts P. J., Anderson S. D. Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J Neurochem. 1979 May;32(5):1539–1545. doi: 10.1111/j.1471-4159.1979.tb11096.x. [DOI] [PubMed] [Google Scholar]
  18. Roberts P. J., McBean G. J., Sharif N. A., Thomas E. M. Striatal glutamatergic function: modifications following specific lesions. Brain Res. 1982 Mar 4;235(1):83–91. doi: 10.1016/0006-8993(82)90197-4. [DOI] [PubMed] [Google Scholar]
  19. Sawynok J., Jhamandas K. H. Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exp Ther. 1976 May;197(2):379–390. [PubMed] [Google Scholar]
  20. Starke K., Reimann W., Zumstein A., Hertting G. Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;305(1):27–36. doi: 10.1007/BF00497003. [DOI] [PubMed] [Google Scholar]
  21. Subramanian N., Mitznegg P., Sprügel W., Domschke W., Domschke S., Wünsch E., Demling L. Influence of enkephalin on K+-evoked efflux of putative neurotransmitters in rat brain. Selective inhibition of acetylcholine and dopamine release. Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):163–165. doi: 10.1007/BF00498558. [DOI] [PubMed] [Google Scholar]
  22. Wood P. L. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides. 1983 Sep-Oct;4(5):595–601. doi: 10.1016/0196-9781(83)90003-7. [DOI] [PubMed] [Google Scholar]
  23. Wüster M., Schulz R., Herz A. Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors. Neurosci Lett. 1979 Dec;15(2-3):193–198. doi: 10.1016/0304-3940(79)96112-3. [DOI] [PubMed] [Google Scholar]
  24. Zieglgänsberger W., Bayerl H. The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res. 1976 Oct 8;115(1):111–128. doi: 10.1016/0006-8993(76)90826-x. [DOI] [PubMed] [Google Scholar]
  25. de Belleroche J. S., Bradford H. F. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J Neurochem. 1980 Nov;35(5):1227–1234. doi: 10.1111/j.1471-4159.1980.tb07879.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES